SCHEMBL6404730

SCHEMBL6404730

CN(C)c1ccccc1C(=O)NNC(=O)c1cc2cc(Cl)ccc2[nH]1.Cc1ccc(S(=O)(=O)O)cc1

nearest known ligand 0.54

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
BCAT1 P54687 4/20 0.54
NHERF1 O14745 1/20 0.49
PYGL P06737 10/20 0.46
HRH4 Q9H3N8 2/20 0.45
HRH3 Q9Y5N1 1/20 0.45
CNR1 P21554 1/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6400057 0.89 NHERF1 (0.60) BCAT1NHERF1PYGLHRH4HRH3
SCHEMBL6402485 0.88 NHERF1 (0.60) BCAT1NHERF1PYGLHRH4KDM4E
SCHEMBL6404154 0.86 BCAT1 (0.53) BCAT1NHERF1PYGLHRH4HRH3
SCHEMBL6398213 0.80 BCAT1 (0.50) BCAT1NHERF1HRH4HRH3
SCHEMBL6405483 0.80 TP53 (0.50) BCAT1HRH4KDM4E
SCHEMBL6400519 0.80 BCAT1 (0.56) BCAT1NHERF1HRH4
SCHEMBL6402489 0.79 NHERF1 (0.56) BCAT1NHERF1PYGLHRH4KDM4E
SCHEMBL6406416 0.78 BCAT1 (0.67) BCAT1NHERF1PYGLHRH4HRH3
SCHEMBL6404156 0.77 BCAT1 (0.51) BCAT1NHERF1PYGLHRH4
SCHEMBL6399671 0.76 TP53 (0.53) BCAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 BCAT1 854/4885NHERF1 332/4885PYGL 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.